Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

171

currently held

Exits tracked

127

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Save searches, build watchlists, pick up where you left off. Free, no credit card.

Start free

241 companies matching · Page 5 of 5

Company	Sector	Geo	Investor	Entry	Status
Crossject Vatel Flexible	Pharma	France	VATEL CAPITAL	2025	Active
Dechra Pharmaceuticals EQT X	Pharma	United Kingdom	EQT	2024	Active
Euro Vital Pharma Apera Private Debt Fund II	Pharma	Germany	Apera Asset Management	2021	Active
Frontier Biosolutions Flerie Invest	Pharma	Germany	Flerie	2023	Active
FrostPharma Priveq Investment VI	Pharma	Sweden	Priveq	2023	Active
Immedica Impilo Investment Pool 1	Pharma	Sweden	Impilo	2018	Active
InfoRLife BC Partners XII	Pharma	Switzerland	BC Partners	2026	Active
itm (ITM) Capmont Private Equity	Pharma	Germany	Capmont	2018	Active
Jubilant Life Sciences General Atlantic	Pharma	India	General Atlantic	–	Active
KalVista Pharmaceuticals Novo Holdings Principal Investments	Pharma	United States	Novo Holdings	2025	Active
Laboratorios Ovejero ADE Capital Sodical	Pharma	Spain	Sodical	2018	Active
LEO Pharma Nordic Capital Fund X	Pharma	Denmark	Nordic Capital	2021	Active
Medison Vitruvian Investment Partnership IV	Pharma	Israel	Vitruvian Partners	2022	Active
Mirum Pharmaceuticals Novo Holdings Growth Investments	Pharma	United States	Novo Holdings	2018	Active
Montplet Corpfin Capital Fund VI	Pharma	Spain	Corpfin Capital	2025	Active
MyCural Therapeutics AB SLU Holding	Pharma	Sweden	SLU Holding	2022	Active
NorthX Biologics Flerie Invest	Pharma	Sweden	Flerie	2021	Active
NUCLIDIUM AG Seedfonds Bayern	Pharma	Switzerland	Bayern Kapital	2025	Active
Orexo Novo Holdings Growth Investments	Pharma	Sweden	Novo Holdings	2010	Active
Orsini Pharmaceutical Services Carlyle Japan	Pharma	Japan	The Carlyle Group	–	Active
Pelago Bioscience Impilo Investment Pool 2	Pharma	Sweden	Impilo	2023	Active
Pentapharm Orlando Capital V	Pharma	Switzerland	Orlando Management	2025	Active
PharMEDium Healthcare Corporation CD&R Other Investments	Pharma	USA	CD&R	–	Active
Pharmivoire Nouvelle IPAE 1	Pharma	Ivory Coast	Investisseurs et Partenaires	2014	Active
Presidio Pharmaceuticals Sobera Capital Fund IV	Pharma	United States	Sobera Capital	2018	Active
Prolevi Bio Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2022	Active
Purpose Pharma Eir Ventures I	Pharma	Sweden	Eir Ventures	2024	Active
Queisser Pharma HGDF Evergreen Holding	Pharma	Germany	HGDF Familienholding	1976	Active
Ritedose Novo Holdings Principal Investments	Pharma	United States	Novo Holdings	2022	Active
Rubicon Research General Atlantic Partners (Bermuda) IV, L.P.	Pharma	United States	General Atlantic	–	Active
Sanfer General Atlantic flagship growth equity fund	Pharma	Mexico	General Atlantic	–	Active
Scantox Impilo Investment Pool 2	Pharma	Denmark	Impilo	2021	Active
Searchlight Pharma Inc. Crédit Mutuel Equity	Pharma	Canada	Crédit Mutuel Equity	2017	Active
Shenzhen Salubris Pharmaceutical Co., Ltd Carlyle Sub-Saharan Africa Fund	Pharma	China	The Carlyle Group	–	Exited
Sobrera Pharma GU Ventures Evergreen	Pharma	Sweden	GU Ventures	2019	Active
Strike Pharma AB SLU Holding	Pharma	Sweden	SLU Holding	2021	Active
Veltio Pharma Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2022	Active
Vicore Pharma HealthCap VII	Pharma	Sweden	HealthCap	2018	Active
Vivunt Pharma ADE Capital Sodical	Pharma	Spain	Sodical	2022	Active
Xellia Pharmaceuticals Novo Holdings Principal Investments	Pharma	Denmark	Novo Holdings	2013	Active
Xspray Pharma Flerie Invest	Pharma	Sweden	Flerie	2021	Active